Pfizer acquires Therachon and its dwarfism drugPfizer has announced it will pay $340 million upfront to snap up rare disease biotech Therachon, which is Share XPfizer acquires Therachon and its dwarfism drughttps://pharmaphorum.com/news/pfizer-acquires-therachon-and-its-dwarfism-drug/